Literature DB >> 29718234

Technical points for aortic valve replacement through right anterior minithoracotomy.

Olivier Bouchot1, Andranik Petrosyan1, Marie Catherine Morgant1, Ghislain Malapert1.   

Abstract

After 8 years of practice and over 400 operated patients, we present a technique of minimally invasive aortic valve replacement that can be used by all surgeons on many patients. The access to the aorta is via the 2nd or 3rd right anterior intercostal space. Cardiopulmonary bypass is provided using the femoral artery and vein. The aorta is clamped directly. One shot of Custodiol (EUSA Pharma, Limonest, France) is the most commonly used cardioplegia. Aortic valve replacement is performed in the regular way. To reduce the aortic cross-clamping time, sutureless or rapid-deployment valves, as well as the Cor-Knot (LSI Solutions, Inc., Victor, NY, USA) automatic knotting system, are excellent options. Right anterior minithoracotomy for aortic valve replacement is safe and reproducible.

Entities:  

Mesh:

Year:  2018        PMID: 29718234     DOI: 10.1093/ejcts/ezy105

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

1.  Stonehenge technique is associated with faster aortic clamp time in group of minimally invasive aortic valve replacement via right infra-axillary thoracotomy.

Authors:  Masataka Yamazaki; Akihiro Yoshitake; Tatsuo Takahashi; Tsutomu Ito; Naritaka Kimura; Akinori Hirano; Yasunori Iida; Shuichiro Takanashi; Hideyuki Shimizu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-08-16

Review 2.  Minimal access in cardiac surgery.

Authors:  Burak Onan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-10-21       Impact factor: 0.332

3.  Eligibility for minithoracotomy aortic valve replacement: from Van Praet classification to complex scanner measurements.

Authors:  Yann Barthelemy; Lionel Camilleri; Bruno Pereira; Mehdi Farhat; Lucie Cassagnes; Nicolas d'Ostrevy
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.